2026 Rett Rounds Series: A Digital On-Demand Expert Roundtable Case Conference Series

Managing Rett Syndrome: Building a Multidisciplinary Care Approach

MinuteCE®
ReachMD Healthcare Image
Media formats available:
Details
Episodes
Presenters
  • Overview

    This MinuteCE activity examines the diagnosis and longitudinal management of Rett syndrome across pediatric and adult populations. Faculty experts discuss classic and atypical clinical presentations, differential diagnosis, and the role of genetic testing in supporting accurate diagnosis and earlier recognition. The series also reviews individualized multidisciplinary management strategies, including seizure control, nutritional and respiratory support, rehabilitation therapies, communication approaches, orthopedic surveillance, and behavioral health considerations. Additional discussions address the integration of trofinetide into care plans, transition to adult care, reproductive health, care coordination, and caregiver support across the lifespan.

  • Disclosure of Relevant Financial Relationships

    In accordance with the ACCME Standards for Integrity and Independence, Global Learning Collaborative requires all faculty and planners to disclose financial relationships with ineligible companies. All relevant financial relationships have been reviewed and mitigated to ensure that the content is free from commercial bias.

    The following faculty and planners have disclosed relevant financial relationships with ineligible companies in the past 24 months.

    Faculty: 
    Edward Dabrowski, MD

    Division/Section Chief, Pediatric PM&R
    Department of Pediatrics
    Corewell Health William Beaumont University Hospital
    Royal Oak, MI 

    Consulting Fees: Acadia, Ipsen

    Payal Kenia Gu, MD 
    Assistant Professor of Pediatrics and Neurology
    Children’s Hospital of Los Angeles
    Los Angeles, CA

    Research: NIH

    David N. Lieberman, MD
    Child Neurologist
    Neurology
    Boston Children’s Hospital
    Boston, MA

    Research: Acadia Pharmaceuticals, Neurogene, Taysha Gene Therapies
    Consulting Fees: Acadia Pharmaceuticals, Neurogene, Taysha Gene Therapies

    Jennifer Martelle Tu, MD, PhD
    Director of Katie’s Clinic for Rett Syndrome
    Neurology
    UCSF Benioff Children’s Hospitals
    Oakland, CA

    Research: Neurogene, Taysha Gene Therapies

    Reviewers/Planners/Authors: 

    • Cindy Davidson has no relevant relationships to disclose. 
    • Parul Yadav, MD, has no relevant relationships to disclose. 
    • Brian P. McDonough, MD, FAAF, has no relevant relationships to disclose. 
  • Learning Objectives

    Upon completion of this activity, learners should be better able to:

    • Integrate knowledge of Rett syndrome (RTT) clinical heterogeneity to enhance diagnostic precision in children as well as in adolescents and adults
    • Recognize signs of incomplete or misclassified RTT to prompt appropriate genetic testing to confirm an accurate diagnosis
    • Apply individualized treatment strategies that reflect the treatment heterogeneity of RTT
  • Target Audience

    This activity has been designed to meet the educational needs of neurologists and pediatricians as well as all other physicians, physician assistants, nurse practitioners, nurses, pharmacists, and healthcare professionals involved in managing patients with Rett syndrome. 

  • Accreditation and Credit Designation Statements

    In support of improving patient care, Global Learning Collaborative is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team. 

    Global Learning Collaborative designates this enduring activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Global Learning Collaborative designates this activity for 1.00 nursing contact hour(s). Nurses should claim only the credit commensurate with the extent of their participation in the activity. 

    Global Learning Collaborative designates this activity for 1.00 contact hour(s)/0.10 CEUs of pharmacy contact hour(s).

    The Universal Activity Number for this program is JA4008106-0000-26-029-H01-P. This learning activity is knowledge-based. Your CE credits will be electronically submitted to the NABP upon successful completion of the activity. Pharmacists with questions can contact NABP customer service (custserv@nabp.net). 

    Global Learning Collaborative has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit(s) for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.00 AAPA Category 1 CME credit(s). Approval is valid until 07/17/2027. PAs should claim only the credit commensurate with the extent of their participation in the activity.  

  • Provider(s)/Educational Partner(s)


    Global Learning Collaborative (GLC) designs and executes continuing education rooted in evidence-based medicine, clinical need, knowledge gap analysis, and careful consideration of learner feedback. Our mission is to serve as an inventive and relevant resource for clinical content and educational interventions across a broad spectrum of specialties. GLC’s methodology is founded on a commitment to continuing medical education and the innovative assessment of its effects on clinical practice. Our goal is clear—to develop and deliver the best education in the most impactful manner and to verify its results with progressive outcomes research.

  • Commercial Support

    This activity is supported by an independent educational grant from Acadia.

  • Disclaimer

    The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of GLC. This presentation is not intended to define an exclusive course of patient management; the participant should use his/her clinical judgment, knowledge, experience, and diagnostic skills in applying or adopting for professional use any of the information provided herein. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients’ conditions and contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. Links to other sites may be provided as additional sources of information.

    Reproduction Prohibited
    Reproduction of this material is not permitted without written permission from the copyright owner. 

  • System Requirements

    • Supported Browsers (2 most recent versions):
      • Google Chrome for Windows, Mac OS, iOS, and Android
      • Apple Safari for Mac OS and iOS
      • Mozilla Firefox for Windows, Mac OS, iOS, and Android
      • Microsoft Edge for Windows
    • Recommended Internet Speed: 5Mbps+

  • Publication Dates

    Release Date:

    Expiration Date:

Register

We're glad to see you're enjoying Global Neurology Academy…
but how about a more personalized experience?

Register for free